メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
病態制御薬理学研究室
富山大学
薬学・和漢系
概要
フィンガープリント
ネットワーク
プロファイル
(2)
プロジェクト
(31)
研究成果
(167)
データセット
(6)
受賞
(4)
活動
(245)
フィンガープリント
病態制御薬理学研究室が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
2-Deoxyglucose Uptake
6%
3T3-L1 Adipocytes
28%
Adipocyte
6%
Adipose Tissue
8%
Akt Phosphorylation
8%
Alkaloids
14%
Autophosphorylation
7%
Blood Glucose
8%
Brain-derived Neurotrophic Factor
5%
Chronic Inflammation
6%
Cleavage Site
6%
Coenzyme Q10
6%
Complementary DNA (cDNA)
6%
Db Mouse
13%
Diabetic
9%
Diabetic Mice
7%
Diet-induced Obesity
6%
Disubstituted
6%
DNA Synthesis
5%
Epidermal Growth Factor
12%
Epidermal Growth Factor Receptor
6%
Epididymal White Adipose Tissue
5%
Extreme Insulin Resistance
7%
Fibroblasts
31%
Functional Importance
6%
Functional Role
5%
Glucose Homeostasis
6%
Glucose Intolerance
5%
Glucose Metabolism
25%
Glucose Uptake
11%
Glycogen Synthesis
5%
Grb2
8%
Growth Factors
20%
Guanine nucleotide Exchange Factor
5%
High-fat Diet
10%
High-fat Diet Mice
6%
Human Insulin Receptor
7%
Human Umbilical Vein Endothelial Cells (HUVECs)
6%
Indolizidine
9%
Inhibitory Effect
6%
Inositol Phosphatase
34%
Insulin
100%
Insulin Action
6%
Insulin Binding
13%
Insulin Growth Factor
7%
Insulin Receptor
56%
Insulin Receptor Substrate 1 (IRS1)
25%
Insulin Resistance
50%
Insulin Sensitivity
8%
Insulin Signaling
32%
Insulin Stimulation
8%
Insulin-like
17%
Insulin-like Growth Factor 1 Receptor (IGF1R)
6%
Insulin-like Growth factor-1
7%
Kinase Activity
9%
Lipid Phosphatase
8%
Liver
9%
Lymphocytes
7%
Microinjection
6%
Mitogen-activated Protein Kinase
12%
Mitogenesis
11%
Mitogenic Signaling
6%
Mouse Model
6%
Mutant Insulin
9%
Negative Regulation
5%
Negatively Regulate
5%
Nicotine
5%
Nicotinic Acetylcholine Receptor (nAChR)
14%
Nicotinic Receptors
8%
Nonalcoholic Steatohepatitis
5%
Obesity
13%
Orexin
21%
Orexin System
7%
Overexpressing
11%
Overexpression
6%
P21Ras
9%
Pericytes
5%
Phosphoinositide 3-kinase (PI3K)
18%
Phosphorylation
23%
Plasma Membrane
9%
Platelet-derived Growth Factor Receptor (PDGFR)
6%
Platelet-derived Growth factor-BB (PDGF-BB)
12%
Point mutation
6%
Poison Frog
9%
Protein Kinase
7%
Rat1
12%
SH3 Domain
15%
SHIP2
11%
Signaling Pathway
6%
Skeletal muscle
5%
Type 2 Diabetes Mellitus (T2DM)
14%
Type 2 Diabetic Patients
6%
Tyrosine
7%
Tyrosine Phosphorylation
17%
Biochemistry, Genetics and Molecular Biology
2-Deoxy-D-Glucose
6%
3T3-L1
23%
Adipocyte
31%
Amino Acids
6%
Arginine
6%
Autophosphorylation
8%
Bromodeoxyuridine
5%
C-Terminus
5%
Cell Membrane
8%
Db/Db Mouse
7%
DNA Synthesis
7%
Epidermal Growth Factor
9%
Epidermal Growth Factor Receptor
6%
Fibroblast
25%
Glucose Blood Level
7%
Glucose Metabolism
19%
Glucose Transport
10%
Glycogenesis
5%
Guanine Nucleotide Exchange Factor
5%
Inositol
34%
Insulin Binding
10%
Insulin Receptor
64%
Insulin Resistance
51%
Insulin Sensitivity
7%
Insulin Signaling
32%
Insulin-Like Growth Factor 1
13%
Insulin-Like Growth Factor 1 Receptor
5%
Kinase
10%
Knockout Mouse
6%
Lipid
8%
Lymphocyte
6%
Macrophage
5%
Messenger RNA
7%
Mitogen-Activated Protein Kinase
15%
Mitogenesis
10%
Orexin
20%
Pericyte
5%
Phosphatase
36%
Phosphoinositide 3-Kinase
19%
Phosphotransferase
10%
Platelet Derived Growth Factor B
5%
Platelet-Derived Growth Factor
7%
Point Mutation
6%
Receptor Binding
6%
Signal Transduction
16%
Skeletal Muscle
8%
Tumor Necrosis Factor
6%
Tyrosine
8%
Tyrosine Phosphorylation
12%
Wild Type
17%
Pharmacology, Toxicology and Pharmaceutical Science
Anura
8%
Broxuridine
6%
Db/Db Mouse
11%
Deoxyglucose
5%
Diabetes Mellitus
11%
Epidermal Growth Factor
8%
Human Insulin
9%
Indolizidine Derivative
8%
Inositol
6%
Insulin Receptor
29%
Insulin Receptor Substrate 1
12%
Insulin Resistance
37%
Messenger RNA
7%
Mitogen Activated Protein Kinase
10%
Mouse Model
7%
Nicotinic Receptor
15%
Non Insulin Dependent Diabetes Mellitus
12%
Orexin
15%
Phosphatase
8%
Phosphatidylinositol 3 Kinase
12%
Protein Kinase C
6%
Receptor
20%
Recombinant Human Insulin
9%
Somatomedin
6%
Somatomedin C
10%
Ubidecarenone
6%